{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:26:24Z","timestamp":1780392384082,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.mrfmmm.2025.111920","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:32:25Z","timestamp":1763692345000},"page":"111920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["FOXA2 promotes glutamine metabolism to facilitate the malignant development of bladder cancer by transcriptionally increasing GLS1 expression"],"prefix":"10.1016","volume":"831","author":[{"given":"Quan","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4423-7179","authenticated-orcid":false,"given":"Jinxian","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrfmmm.2025.111920_bib1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3390\/medicina57080749","article-title":"Bladder cancer: current challenges and future directions","volume":"57","author":"Dobruch","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/j.mrfmmm.2025.111920_bib2","doi-asserted-by":"crossref","first-page":"9854","DOI":"10.3390\/ijms24129854","article-title":"Epigenetic and immunological features of bladder cancer","volume":"24","author":"Gilyazova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib3","first-page":"380","article-title":"Identifying prostaglandin D2 synthase in urine: a potential biomarker for bladder cancer","volume":"21","author":"Lia-Beng","year":"2024","journal-title":"Curr. Proteom."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib4","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1186\/s12885-022-10244-9","article-title":"Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990\u20132019 and their predictions to 2030","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.mrfmmm.2025.111920_bib5","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3390\/diagnostics11101793","article-title":"Multiple chromatographic analysis of urine in the detection of bladder cancer","volume":"11","author":"Dzubinska","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.mrfmmm.2025.111920_bib6","article-title":"Acute urinary retention and risk of cancer: population based Danish cohort study","volume":"375","author":"Bengtsen","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.mrfmmm.2025.111920_bib7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.celrep.2019.06.034","article-title":"FOXA2 Is Required for enhancer priming during pancreatic differentiation","volume":"28","author":"Lee","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41420-024-01936-1","article-title":"FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer","volume":"10","author":"Liu","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41419-023-05732-0","article-title":"Radiation induces IRAK1 expression to promote radioresistance by suppressing autophagic cell death via decreasing the ubiquitination of PRDX1 in glioma cells","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/gutjnl-2022-326987","article-title":"FOXA2 prevents hyperbilirubinaemia in acute liver failure by maintaining apical MRP2 expression","volume":"72","author":"Wang","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.mrfmmm.2025.111920_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202304521","article-title":"FOXA2 suppression by TRIM36 exerts anti-tumor role in colorectal cancer via inducing NRF2\/GPX4-regulated ferroptosis","volume":"10","author":"Liu","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbrc.2022.07.085","article-title":"FOXA2 promotes esophageal cancer migration and metastasis by activating CXCR4 expression","volume":"625","author":"Chen","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nrurol.2016.239","article-title":"On a FOX hunt: functions of FOX transcriptional regulators in bladder cancer","volume":"14","author":"Yamashita","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib14","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","article-title":"Targeting glutamine metabolism as a therapeutic strategy for cancer","volume":"55","author":"Jin","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib15","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","article-title":"Enhancing the efficacy of glutamine metabolism inhibitors in cancer therapy","volume":"7","author":"Yang","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.mrfmmm.2025.111920_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155952","article-title":"The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis","volume":"158","author":"Mercado-Gomez","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.mrfmmm.2025.111920_bib17","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bcp.2018.08.032","article-title":"Glutaminase-1 stimulates the proliferation, migration, and survival of human endothelial cells","volume":"156","author":"Peyton","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib18","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1007\/s12094-021-02645-2","article-title":"Targeting GLS1 to cancer therapy through glutamine metabolism","volume":"23","author":"Yu","year":"2021","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2021.108964","article-title":"GLS1 depletion inhibited colorectal cancer proliferation and migration via redox\/Nrf2\/autophagy-dependent pathway","volume":"708","author":"Liu","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.70036","article-title":"Glutaminase-1 mediated glutaminolysis to glutathione synthesis maintains redox homeostasis and modulates ferroptosis sensitivity in cancer cells","author":"Bai","year":"2025","journal-title":"Cell Prolif."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib21","doi-asserted-by":"crossref","first-page":"7433","DOI":"10.1182\/bloodadvances.2023010964","article-title":"Inhibition of glutaminase-1 in DLBCL potentiates venetoclax-induced antitumor activity by promoting oxidative stress","volume":"7","author":"Gomez Solsona","year":"2023","journal-title":"Blood Adv."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib22","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.molcel.2022.03.016","article-title":"Filamentous GLS1 promotes ROS-induced apoptosis upon glutamine deprivation via insufficient asparagine synthesis","volume":"82","author":"Jiang","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.mrfmmm.2025.111920_bib23","article-title":"Inhibition of GLS1 and ASCT2 synergistically enhances the anticancer effects in pancreatic cancer cells","volume":"35","author":"Kim","year":"2025","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41416-022-02058-0","article-title":"Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression to reduce sensitivity to cisplatin in bladder cancer","volume":"128","author":"Ren","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.mrfmmm.2025.111920_bib25","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1186\/s12967-023-04311-3","article-title":"Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression","volume":"21","author":"Liu","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib26","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.4081\/ejh.2025.4221","article-title":"NR4A3 suppresses bladder cancer progression by modulating autophagy via the PI3K\/AKT\/mTOR pathway","volume":"69","author":"Fan","year":"2025","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102104","article-title":"The role of deubiquitinase USP2 in driving bladder cancer progression by stabilizing EZH2 to epigenetically silence SOX1 expression","volume":"49","author":"Xu","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13062-025-00597-z","article-title":"Methyltransferase-like 7B participates in bladder cancer via ACSL3 m(6)A modification in a ferroptosis manner","volume":"20","author":"He","year":"2025","journal-title":"Biol. Direct"},{"key":"10.1016\/j.mrfmmm.2025.111920_bib29","first-page":"183","article-title":"CTHRC1 facilitates bladder cancer cell proliferation and invasion through regulating the PI3K\/Akt signaling pathway","volume":"18","author":"Li","year":"2022","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269214","article-title":"The expression of stem cells markers and its effects on the propensity for recurrence and metastasis in bladder cancer: a systematic review","volume":"18","author":"Hamid","year":"2023","journal-title":"PLOS One"},{"key":"10.1016\/j.mrfmmm.2025.111920_bib31","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s13402-023-00820-x","article-title":"Single-cell RNA sequencing reveals the cellular and molecular characteristics of high-grade and metastatic bladder cancer","volume":"46","author":"Zheng","year":"2023","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eururo.2022.04.017","article-title":"Chemoradiotherapy in muscle-invasive bladder cancer: 10-yr follow-up of the phase 3 randomised controlled BC2001 trial","volume":"82","author":"Hall","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib33","first-page":"5619","article-title":"FOXA2 promotes prostate cancer growth in the bone","volume":"12","author":"Connelly","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.108840","article-title":"NatD epigenetically activates FOXA2 expression to promote breast cancer progression by facilitating MMP14 expression","volume":"27","author":"Xing","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.mrfmmm.2025.111920_bib35","first-page":"306","article-title":"Forkhead box A2 promotes colorectal cancer progression and targets BCL2-associated X (BAX) protein, Iran","volume":"52","author":"Zeng","year":"2023","journal-title":"J. Public Health"},{"key":"10.1016\/j.mrfmmm.2025.111920_bib36","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1172\/JCI69600","article-title":"Glutamine and cancer: cell biology, physiology, and clinical opportunities","volume":"123","author":"Hensley","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib37","doi-asserted-by":"crossref","first-page":"2539S","DOI":"10.1093\/jn\/131.9.2539S","article-title":"Glutamine and cancer","volume":"131","author":"Medina","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s43018-020-00160-x","article-title":"Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma","volume":"2","author":"Wu","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.mrfmmm.2025.111920_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115306","article-title":"Targeting glutaminase 1 (GLS1) by small molecules for anticancer therapeutics","volume":"252","author":"Chen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.mrfmmm.2025.111920_bib40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1021\/acsmedchemlett.6b00016","article-title":"Glutaminase GLS1 inhibitors as potential cancer treatment","volume":"7","author":"Abdel-Magid","year":"2016","journal-title":"ACS Med. Chem. Lett."}],"container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510725000235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510725000235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T11:11:08Z","timestamp":1773918668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027510725000235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":40,"alternative-id":["S0027510725000235"],"URL":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2025.111920","relation":{},"ISSN":["1386-1964"],"issn-type":[{"value":"1386-1964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FOXA2 promotes glutamine metabolism to facilitate the malignant development of bladder cancer by transcriptionally increasing GLS1 expression","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2025.111920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111920"}}